Lucky completed her undergraduate degree in Medical Biochemistry at Kingston University in 2014, where her passion for microbiology originated through summer research internships and a research scholarship funded by the British Society for Antimicrobial Chemotherapy (BSAC). A recurring factor in all of her research was antimicrobial resistance including next generation sequencing techniques to identify antimicrobial resistance within the nasopharyngeal niche, pseudomonas aeruginosa biofilm formation and the bacterial profiling of mastitic cows. Lucky progressed onto a PhD at Kingston University, where she developed an experimental evolution tool to explore the phenotypic and genotypic mutational pathways underlying the emergence of antimicrobial resistance in Escherichia coli. During her PhD Lucky attended many ECS and AMI conferences, as well as events such as Parliamentary Links Day. Lucky presented her research at the ECS Research Symposium in 2016, and was given the opportunity to present at the AMI Antimicrobial Resistance Meeting. Lucky was then awarded the SfAM presidency fund to present at the American Society for Microbiology (ASM) conference in New Orleans.
Short-term research contracts and the effects of COVID-19
Most researchers are driven by intellectual curiosity rather than the desire for financial reward, but for post-docs, who can spend years on a succession of short-term contracts, this can make a career in science an unattractive option